A systematic review and meta-analysis on PD-L1 expression in this patient population undergoing immunotherapy, encompassing 11 clinical trials and 1330 patients with advanced HCC, found that PD-L1 expression was associated with a significantly higher ORR (26% vs. 18%) but not DCR [97]. Here, CD274 is linked to hepatocellular carcinoma.